Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0–5 years Old Polish Children
Abstract
:1. Introduction
2. Materials and Methods
2.1. Design and Setting
2.2. Study Population and Sampling
2.3. Study Instrument and Data Collection
2.4. Statistical Analysis
3. Results
3.1. Sociodemographic Characteristics
3.2. Sources of Knowledge about Meningococcal Disease
3.3. Knowledge about Meningococcal Disease
3.4. Previous Information about Meningococcal Disease
3.5. Parental Attitudes Towards Vaccines
3.6. Factors Influencing Knowledge about Meningococcal Infection
3.7. Vaccination Uptake among Children
4. Discussion
4.1. Results Overview
4.2. Meningococcal Vaccination Uptake
4.3. Awareness of IMD
4.4. Knowledge about Meningococcal Infection
4.5. Parental Attitudes Towards Vaccination
4.6. Determinants of Parental Knowledge about Meningococcal Infection
5. Limitations
6. Implications for Educational Interventions
7. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- European Centre for Disease Prevention and Control. Invasive meningococcal disease. In ECDC. Annual Epidemiological Report for 2016; ECDC: Stockholm, Sweden, 2018. [Google Scholar]
- Morrone, T.; Napolitano, F.; Albano, L.; Di Giuseppe, G. Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy. Hum. Vaccin. Immunother. 2017, 13, 1921–1927. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mameli, C.; Faccini, M.; Mazzali, C.; Picca, M.; Colella, G.; Duca, P.G.; Zuccotti, G.V. Acceptability of meningococcal serogroup B vaccine among parents and health care workers in Italy: A survey. Hum. Vaccin. Immunother. 2014, 10, 3004–3010. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Paradowska-Stankiewicz, I.; Piotrowska, A. Menigitis and encephalitis in Poland in 2015. Przeg. Epidemiol. 2017, 74, 493–500. [Google Scholar]
- Sadkowska-Todys, M.; Zieliński, A.; Czarkowski, M.P. Infectious diseases in Poland in 2016. Przeg. Epidemiol. 2018, 72, 129–141. [Google Scholar]
- Konior, R. Should Vaccination against Meningococcal Disease Be Mandatory? Available online: https://www.mp.pl/szczepienia/186451 (accessed on 15 November 2017).
- Czajka, H.; Dzierżanowska-Fangrat, K.; Konior, R.; Kuchar, E.; Stryczyńska-Kazubska, J.; Skoczyńska, A.; Szenborn, L.; Wysocki, J. Prophylaxis of invasive meningococcal disease in children, adolescents and adults. Med. Prakt. (special edition). 2017, 1, 1/2017. [Google Scholar]
- Van Ravenhorst, M.B.; den Hartog, G.; van der Klis, F.R.M.; van Rooijen, D.M.; Sanders, E.A.M.; Berbers, G.A.M. Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine. PLoS ONE 2018, 13, e0191261. [Google Scholar] [CrossRef] [PubMed]
- Keshavan, P.; Pellegrini, M.; Vadivelu-Pechai, K.; Nissen, M. An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine. Expert Rev. Vaccines 2018, 17, 865–880. [Google Scholar] [CrossRef] [PubMed]
- Flacco, M.E.; Manzoli, L.; Rosso, A.; Marzuillo, C.; Bergamini, M.; Stefanati, A.; Cultrera, R.; Villari, P.; Ricciardi, W.; Ioannidis, J.P.A.; Contopoulos-Ioannidis, D.G. Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: A systematic review and meta-analysis. Lancet Infect. Dis. 2018, 18, 461–472. [Google Scholar] [CrossRef]
- Vogel, U.; Taha, M.K.; Vazquez, J.A.; Findlow, J.; Claus, H.; Stefanelli, P.; Caugant, D.A.; Kriz, P.; Abad, R.; Bambini, S.; et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: A qualitative and quantitative assessment. Lancet Infect. Dis. 2013, 13, 416–425. [Google Scholar] [CrossRef]
- Rotter, C.L.; Ramsay, M.E. Vaccination against meningococcal disease in Europe: Review and recommendations for the use of conjugate vaccines. FEMS Microbiol. Rev. 2007, 31, 101–107. [Google Scholar] [CrossRef]
- Wise, J. Teenagers in England to be vaccinated against meningitis group W. BMJ 2015, 350, h1486. [Google Scholar] [CrossRef]
- Parikh, S.R.; Andrews, N.J.; Beebeejaun, K.; Campbell, H.; Ribeiro, S.; Ward, C.; White, J.M.; Borrow, R.; Ramsay, M.E.; Ladhani, S.N. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: A national observational cohort study. Lancet 2016, 388, 2775–2782. [Google Scholar] [CrossRef]
- Chief Sanitary Inspectorate. Polish National Immunization Program 2019. Available online: https://gis.gov.pl/wp-content/uploads/2018/01/akt.pdf (accessed on 15 December 2018).
- National Institute of Hygiene. Mandatory Vaccinations in Poland—History and Rationale. Available online: http://szczepienia.pzh.gov.pl/en/stories/mandatory-vaccinations-in-poland/ (accessed on 15 November 2017).
- Reduction of the mandatory vaccination uptake in Poland. In Vaccinations in Poland in 2017; National Institute of Public Health—National Institute of Hygiene, Department of Epidemiology and Surveillance of Infectious Diseases, Chief Sanitary Inspectorate—Department for Communicable Disease and Infection Prevention and Control: Warsaw, Poland, 2018. Available online: http://wwwold.pzh.gov.pl/oldpage/ epimeld/index_p.html#05 (accessed on 17 December 2018).
- Jackson, C.; Yarwood, J.; Saliba, V.; Bedford, H. UK parents’ attitudes towards meningococcal group B (MenB) vaccination: A qualitative analysis. BMJ Open 2017, 7, e012851. [Google Scholar] [CrossRef] [PubMed]
- Dubé, E.; Gagnon, D.; Hamel, D.; Belley, S.; Gagné, H.; Boulianne, N.; Landry, M.; Bettinger, J.A. Parents’ and adolescents’ willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay-Lac-St-Jean (Quebec). Can. J. Infect. Dis. Med. Microbiol. 2015, 26, 163–167. [Google Scholar] [CrossRef] [PubMed]
- Le Ngoc Tho, S.; Ader, F.; Ferry, T.; Floret, D.; Arnal, M.; Fargeas, S.; Chidiac, C.; Valour, F. Vaccination against serogroup B Neisseria meningitidis: Perceptions and attitudes of parents. Vaccine 2015, 33, 3463–3470. [Google Scholar] [CrossRef] [PubMed]
- Marshall, H.; Clarke, M.; Sullivan, T. Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines. Vaccine 2014, 32, 338–344. [Google Scholar] [CrossRef] [PubMed]
- Bakhache, P.; Rodrigo, C.; Davie, S.; Ahuja, A.; Sudovar, B.; Crudup, T.; Rose, M. Health care providers’ and parents’ attitudes toward administration of new infant vaccines—A multi-national survey. Eur. J. Pediatr. 2013, 172, 485–492. [Google Scholar] [CrossRef] [PubMed]
- Bedford, H.; Lansley, M. More vaccines for children? Parents’ views. Vaccine 2007, 25, 7818–7823. [Google Scholar] [CrossRef] [PubMed]
- Kawakatsu, Y.; Honda, S. Individual-, family- and community-level determinants of full vaccination coverage among children aged 12–23 months in western Kenya. Vaccine 2012, 30, 7588–7593. [Google Scholar] [CrossRef]
- Samadi, I.; Tate, A.R.; Dezateux, C.; Peckham, C.; Butler, N.; Bedford, H. Differences in risk factors for partial and no immunization in the first year of life: Prospective cohort study. Br. Med. J. 2006, 332, 1312–1313. [Google Scholar] [CrossRef]
- Available online: https://stat.gov.pl/obszary-tematyczne/roczniki-statystyczne/roczniki-statystyczne/rocznik-statystyczny-rzeczypospolitej-polskiej-2017,2,17.html (accessed on 8 December 2018).
- Ganczak, M.; Dmytrzyk-Daniłów, G.; Karakiewicz, B.; Korzeń, M.; Szych, Z. Determinants influencing self-paid vaccination coverage, in 0–5 years old Polish children. Vaccine 2013, 31, 5687–5692. [Google Scholar] [CrossRef] [PubMed]
- Daniel, W.W. Biostatistics: A Foundation for Analysis in the Health Sciences, 6th ed.; John Wiley & Sons, Inc.: New York, NY, USA, 1995; p. 180. [Google Scholar]
- Larson, H.J.; Jarret, C.; Schulz, W.S.; Chaudhuri, M.; Zhou, Y.; Dube, E.; Schuster, M.; MacDonald, N.E.; Wilson, R. Measuring vaccine hesitancy: The development of a survey tool. Vaccine 2015, 33, 4165–4175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Edwards, P.J.; Roberts, I.; Clarke, M.J.; Di Guiseppi, C.; Wentz, R.; Kwan, I.; Cooper, R.; Felix, L.M.; Pratap, S. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst. Rev. 2009, 3, MR000008. [Google Scholar] [CrossRef] [PubMed]
- Edwards, P. Questionnaires in Clinical Trials: Guidelines for Optimal Design and Administration. Trials 2010, 11, 2. Available online: http://www.trialsjournal.com/content/11/1/2 (accessed on 5 November 2018). [CrossRef] [PubMed]
- Hosmer, D.W.; Lemeshow, S. Applied Logistic Regression, 2nd ed.; John Wiley & Sons Inc.: New York, NY, USA; Chichester, UK; Weinheim, Germany; Brisbane, Australia; Singapore; Toronto, ON, Canada, 2000. [Google Scholar]
- Venables, W.N.; Ripley, B.D. Modern Applied Statistics with S, 4th ed.; Springer: New York, NY, USA, 2002. [Google Scholar]
- R Development Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2008. [Google Scholar]
- Pieszka, M.; Waksmańska, W.; Woś, H. Knowledge of immunization among parents of children under two years of age. Med. Og. Nauk. Zdr. 2016, 22, 221–226. [Google Scholar] [CrossRef]
- Nitsch-Osuch, A.; Kozerska, A.; Topczewska-Cabanek, A.; Życińska, K.; Wardyn, K.A. Realization of immunization schedule with recommended vaccines among children from one general practice. Fam. Med. Prim. Care Rev. 2012, 14, 339–341. [Google Scholar]
- Vielot, N.A.; Butler, A.M.; Brookhart, M.A.; Becker-Dreps, S.; Smith, J.S. Patterns of use of human papillomavirus and other adolescent vaccines in the United States. J. Adolesc. Health 2017, 61, 281–287. [Google Scholar] [CrossRef]
- Malerba, V.; Costantino, C.; Napoli, G.; Marchese, V.; Casuccio, A.; Tabacchi, G.; Vitale, F. Anti-menigococcal and antipneumococcal vaccination determinants: A European literature review. Epidemiol. Prev. 2015, 39, 59–64. [Google Scholar]
- Sheikh, S.; Biundo, E.; Courcier, S.; Damm, O.; Launay, O.; Maes, E.; Marcos, C.; Matthews, S.; Meije, C.; Poscia, A.; et al. A report on the status of vaccination in Europe. Vaccine 2018, 36, 4979–4992. [Google Scholar] [CrossRef]
- Ali, A.; Jafri, R.Z.; Messonnier, N.; Tevi-Benissan, C.; Durrheim, D.; Eskola, J.; Fermon, F.; Klugman, K.P.; Ramsay, M.; Sow, S.; et al. Global practices of meningococcal vaccine use and impact on invasive disease. Pathog. Glob. Health 2014, 108, 11–20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kuhdari, P.; Stefanati, A.; Lupi, S.; Valente, N.; Gabutti, G. Meningococcal B vaccination: Real-world experience and future perspectives. Pathog. Glob. Health 2016, 110, 148–156. [Google Scholar] [CrossRef] [PubMed]
- Bryan, P.; Seabroke, S.; Wong, J.; Donegan, K.; Webb, E.; Goldsmith, Ch.; Vipond, C.; Feavers, I. Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: A prospective surveillance study. Lancet. Child Adolesc. Health 2018, 2, 395–403. [Google Scholar] [CrossRef]
- Lakshman, R.; Jones, I.; Walker, D.; McMurtrie, K.; Shaw, L.; Race, G.; Choo, S.; Danzig, L.; Oster, P.; Finn, A. Safety of a new conjugate meningococcal C vaccine in infants. Arch. Dis. Child. 2001, 85, 391–397. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ganczak, M.; Owsianka, B.; Korzeń, M. Factors that predict parental willingness to have their children vaccinated against HPV in a country with low HPV vaccination coverage. Int. J. Environ. Res. Public Health 2018, 15, 625. [Google Scholar] [CrossRef] [PubMed]
- Low, M.S.F.; Tan, H.; Hartman, M.; Tam, C.C.; Hoo, C.; Lim, J.; Chiow, S.; Lee, S.; Thng, R.; Cai, M.; et al. Parental perceptions of childhood seasonal influenza vaccination in Singapore: A cross-sectional survey. Vaccine 2017, 35, 6096–6102. [Google Scholar] [CrossRef] [PubMed]
- Tarczoń, I.; Domaradzka, E.; Czajka, H. What is parents’ and medical health care specialists knowledge about vaccinations? Przegl. Lek. 2009, 66, 27–33. [Google Scholar]
- Wang, B.; Clarke, M.; Afzali, H.H.; Marshall, H. Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine 2014, 32, 2042–2049. [Google Scholar] [CrossRef]
- Harrison, L.H. Epidemiological Profile of Meningococcal Disease in the United States. Clin. Infect. Dis. 2010, 50, S37–S44. [Google Scholar] [CrossRef]
- Theeten, H.; Hens, N.; Vandermeulen, C.; Depoorter, A.M.; Roelants, M.; Aerts, M.; Hoppenbrouwers, K.; Van Damme, P. Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders. Belgium: An EPI-survey. Vaccine 2007, 25, 4940–4948. [Google Scholar] [CrossRef]
- Guttmann, A.; Manuel, D.; Dick, P.T.; To, T.; Lam, K.; Stukel, T.A. Volume matters: Physician practice characteristics and immunization coverage among young children insured through a universal health plan. Pediatrics 2006, 117, 595–602. [Google Scholar] [CrossRef] [PubMed]
- Gordis, L. Epidemiology, 5th ed.; Sanders: Philadelphia, PA, USA, 2014. [Google Scholar]
Variable | n | % |
---|---|---|
Age | ||
≤32 years | 166 | 50.8 |
>32 years | 161 | 49.2 |
Gender of the parent | ||
Male | 46 | 14.1 |
Female | 281 | 85.9 |
Place of residence | ||
Rural area | 87 | 26.6 |
Urban area | 240 | 73.4 |
Facility location | ||
Provincial (Gryfino) | 150 | 45.9 |
Urban (Szczecin) | 177 | 54.1 |
Education level | ||
Primary/vocational | 61 | 18.7 |
High school/university | 266 | 81.3 |
Marital status | ||
Married/Cohabitating | 271 | 82.9 |
Single | 56 | 17.1 |
Number of children | ||
≤2 | 282 | 86.2 |
>2 | 45 | 13.8 |
Employment status | ||
Working | 243 | 74.3 |
Not working | 84 | 25.7 |
Owning a car | ||
Yes | 276 | 85.7 |
No | 46 | 14.3 |
Statement | Correct Answer | True | False | ||
---|---|---|---|---|---|
n | % | n | % | ||
IMD is caused by bacteria | yes | 222 | 67.9 | 105 | 32.1 |
IMD is a life-threatening disease | yes | 183 | 58.7 | 129 | 41.3 |
Bacterial meningitis is transmitted by droplets | yes | 179 | 58.9 | 125 | 41.1 |
Bacterial meningitis could be prevented by vaccinations | yes | 243 | 79.7 | 62 | 20.3 |
Vaccination against meningococci also protects against sepsis | yes | 147 | 47.0 | 166 | 53.0 |
Variable | Adequate Knowledge >2 | Poor Knowledge 0–2 | p | ||
---|---|---|---|---|---|
n | % | n | % | ||
Sociodemographic variables | |||||
Age | |||||
≤32 years | 100 | 30.6 | 66 | 20.2 | 0.91 |
>32 years | 98 | 29.9 | 63 | 19.3 | |
Gender | |||||
Male | 25 | 7.6 | 21 | 6.4 | 0.35 |
Female | 173 | 52.9 | 108 | 33.1 | |
Place of residence | |||||
Rural area | 41 | 12.5 | 46 | 14.1 | 0.002 |
Urban area | 157 | 48.0 | 83 | 25.4 | |
Education level | |||||
Primary/vocational education | 21 | 6.4 | 39 | 11.9 | <0.001 |
Secondary/high education | 177 | 54.2 | 90 | 27.5 | |
Marital status | |||||
Married/Cohabitating | 173 | 52.9 | 98 | 30.0 | 0.007 |
Single | 25 | 7.6 | 31 | 9.5 | |
Number of children | |||||
≤2 | 177 | 54.1 | 105 | 32.1 | 0.04 |
>2 | 21 | 6.4 | 24 | 7.4 | |
Employment status | |||||
Working | 153 | 46.8 | 90 | 27.5 | 0.13 |
Not working | 45 | 13.8 | 39 | 11.9 | |
Owning a car | |||||
Yes | 181 | 55.3 | 100 | 30.6 | <0.001 |
No | 17 | 5.2 | 29 | 8.9 | |
Type of facility | |||||
Urban | 107 | 32.7 | 70 | 21.5 | 0.89 |
Provincial | 91 | 27.8 | 59 | 18.0 | |
Other variables | |||||
Had ever received information about IMD | |||||
Yes | 163 | 52.8 | 61 | 19.7 | <0.001 |
No | 23 | 7.4 | 62 | 20.1 | |
Self-assessed knowledge as good | |||||
Yes | 53 | 16.6 | 7 | 2.2 | <0.001 |
No | 140 | 43.9 | 119 | 37.3 | |
Concerned about the safety of MV | |||||
Yes | 118 | 36.8 | 62 | 19.4 | 0.07 |
No | 78 | 24.4 | 62 | 19.4 |
Variable | OR | CI |
---|---|---|
Parental age: >32 | 1.03 | 0.97–1.09 |
Gender: father | 0.52 | 0.22–1.22 |
Marital status: married/cohabitating | 1.77 | 0.85–3.67 |
Residence: urban | 1.74 | 0.84–3.64 |
Education: high school/university | 3.37 | 1.31–8.85 |
Employment: yes | 1.18 | 0.56–2.42 |
Owning a car: yes | 1.11 | 0.40–3.06 |
Number of children: ≤2 | 1.84 | 0.64–5.30 |
Facility: urban | 2.20 | 1.16–4.33 |
Had ever received information about IMD | 2.85 | 1.29–6.44 |
Self–assessed knowledge: good | 2.59 | 1.08–6.83 |
Source of knowledge: GP | 1.64 | 0.82–3.31 |
Concerned about the safety of MV: yes | 0.99 | 0.53–1.84 |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Drozd-Dąbrowska, M.; Topczewska, K.; Korzeń, M.; Sałacka, A.; Ganczak, M. Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0–5 years Old Polish Children. Int. J. Environ. Res. Public Health 2019, 16, 265. https://doi.org/10.3390/ijerph16020265
Drozd-Dąbrowska M, Topczewska K, Korzeń M, Sałacka A, Ganczak M. Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0–5 years Old Polish Children. International Journal of Environmental Research and Public Health. 2019; 16(2):265. https://doi.org/10.3390/ijerph16020265
Chicago/Turabian StyleDrozd-Dąbrowska, Marzena, Katarzyna Topczewska, Marcin Korzeń, Anna Sałacka, and Maria Ganczak. 2019. "Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0–5 years Old Polish Children" International Journal of Environmental Research and Public Health 16, no. 2: 265. https://doi.org/10.3390/ijerph16020265
APA StyleDrozd-Dąbrowska, M., Topczewska, K., Korzeń, M., Sałacka, A., & Ganczak, M. (2019). Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0–5 years Old Polish Children. International Journal of Environmental Research and Public Health, 16(2), 265. https://doi.org/10.3390/ijerph16020265